Global female infertility diagnosis and treatment market is anticipated to grow at a CAGR of 5.6% during the forecast period (2024-2031). The rising trends of surrogacy, the growing infertility rate among females, and new technologies to avoid multiple embryo implants are estimated to be the major factors that are contributing to the market growth. Advancement in IVF treatments has opened up new potential opportunities with positive results of IVF procedures. It is expected to propel the demand for female infertility diagnosis and treatment market during the forecasted period.

Get Free Sample link @ https://www.omrglobal.com/request-sample/female-infertility-market-size

Recent Developments in the Female Infertility Diagnosis and Treatment Market

In February 2024, Catalent, Inc. and Novo Holdings, announced that they have entered into a merger agreement. Novo Holdings has acquired Catalent in an all-cash transaction, valuing Catalent at $16.5 billion. The acquisition is aimed at Novo Holdings’ mandate to invest in high-quality life sciences companies. 
In September 2023, Femasys Inc., a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage.

Full report of Female Infertility Diagnosis and Treatment Market available @ https://www.omrglobal.com/industry-reports/female-infertility-market-size

Market Coverage

The market number available for – 2023-2031
Base year- 2023
Forecast period- 2024-2031
Segment Covered-

o             By Diagnosis

o             By Treatment

o             By End User

Regions Covered-

o             North America

o             Europe

o             Asia-Pacific

o             Rest of the World

Competitive Landscape- AbbVie Inc., Bayer AG, CooperSurgical Inc., Eli Lilly and Co., and Merck KGaA, among others.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?

Global Female Infertility Diagnosis and Treatment Market Report Segment

By Diagnosis

Ovulation Testing
Hysterosalpingography (HSG)
Hysteroscopy
Imaging Testing
Ovarian Reserve Testing
Hormonal Level Testing
Genetic Testing
Others

By Treatment

Drugs 
Surgery
Intrauterine Insemination (IUI)
Assisted Reproductive Technology (ART)

By End User

Hospitals and Clinics
Homecare
Pathology
Diagnostic Centers

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.




For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/female-infertility-market-size








Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.